Literature DB >> 8302120

Sensorineural hearing loss from quinolinic acid: a neurotoxin in middle ear effusions.

R F Yellon1, E Rose, M A Kenna, W J Doyle, M Casselbrant, W F Diven, T L Whiteside, J D Swarts, M P Heyes.   

Abstract

Quinolinic acid (QUIN) is an endogenous metabolite that exerts a neurotoxic effect by binding to specific neuronal receptors. Studies involving a broad spectrum of infectious and inflammatory central nervous system diseases have suggested a role for QUIN in causing neuronal injury. Since there is evidence for presence of the QUIN receptor in mammalian cochleas, QUIN was measured in middle ear effusions (MEEs). Gas chromatography/mass spectrometry detected QUIN in each of 65 diluted human MEEs, with a mean of 482 +/- 75 (SEM) nmol/L and a range from 15 to 2667 nmol/L. QUIN was also detected in each of 197 chinchilla MEEs from five different models of otitis media, with a mean of 10.6 +/- 1.3 (SEM) mumol/L and a range from 0.23 to 146.0 mumol/L (corrected for dilution). To determine whether QUIN causes sensorineural hearing loss (SNHL), QUIN solutions were placed on round window membranes (RWM) for 20 to 240 minutes, in 20 chinchillas. SNHL was detected by electrocochleography in QUIN-exposed animals, but not in saline controls. We conclude that QUIN is present in MEEs and that QUIN in the middle ear has the potential to cross the RWM and cause sensorineural hearing loss, possibly by binding to specific neuronal receptors in mammalian cochleas.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8302120     DOI: 10.1288/00005537-199402000-00009

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  3 in total

1.  Extracts of retina and brain that excite afferent fibers innervating hair cells contain a compound related to hydroxyphenylglycine-N-carbamoyl.

Authors:  W F Sewell; E A Mroz; J E Evans
Journal:  Synapse       Date:  2005-11       Impact factor: 2.562

2.  Neurotoxicity of quinolinic acid to spiral ganglion cells in rats.

Authors:  Hongjun Xiao; Chen Yang; Yuanyuan He; Na Zheng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-06-17

3.  The N-Methyl-D-Aspartate Receptor Blocker REL-1017 (Esmethadone) Reduces Calcium Influx Induced by Glutamate, Quinolinic Acid, and Gentamicin.

Authors:  Ezio Bettini; Sara De Martin; Andrea Mattarei; Marco Pappagallo; Stephen M Stahl; Francesco Bifari; Charles E Inturrisi; Franco Folli; Sergio Traversa; Paolo L Manfredi
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.